Search Results - "BURGER, Karen"
-
1
Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis
Published in Oncogene (31-10-2019)“…Bone metastatic prostate cancer provokes extensive osteogenesis by driving the recruitment and osteoblastic differentiation of mesenchymal stromal cells…”
Get full text
Journal Article -
2
Src-dependent Tks5 phosphorylation regulates invadopodia-associated invasion in prostate cancer cells
Published in The Prostate (01-02-2014)“…BACKGROUND The Src tyrosine kinase substrate and adaptor protein Tks5 had previously been implicated in the invasive phenotype of normal and transformed cell…”
Get full text
Journal Article -
3
CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma
Published in Cancer research (Chicago, Ill.) (01-12-2023)“…Multiple myeloma remains an incurable malignancy due to acquisition of intrinsic programs that drive therapy resistance. Here we report that casein kinase-1δ…”
Get full text
Journal Article -
4
The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells
Published in Blood advances (14-07-2020)“…The in-clinic phosphatidylinositol 3-kinase (PI3K) inhibitors idelalisib (CAL-101) and duvelisib (IPI-145) have demonstrated high rates of response and…”
Get full text
Journal Article -
5
The podosome marker protein Tks5 regulates macrophage invasive behavior
Published in Cytoskeleton (Hoboken, N.J.) (01-12-2011)“…Tks5 is a Src substrate and adaptor protein previously recognized for its regulation of cancer cell invasion through modulation of specialized adhesion…”
Get full text
Journal Article -
6
A CK1δ/CK1ε Regulated Metabolic Circuit Is a Therapeutic Vulnerability for Multiple Myeloma
Published in Blood (13-11-2019)“…Multiple Myeloma (MM) remains an incurable malignancy, despite the advent of several new therapeutic agents, including immunomodulatory drugs (IMiDs, e.g.,…”
Get full text
Journal Article -
7
A CK1δ/CK1ε-to-Wnt/β-Catenin Circuit Is a Therapeutic Vulnerability in Primary and Drug Resistant Multiple Myeloma
Published in Blood (02-12-2016)“…Aberrant canonical Wnt/β-catenin signaling has long been known to play a role in cancer development and progression, where Wnt binding provokes nuclear…”
Get full text
Journal Article -
8
A CK1δ/CK1ε-to-β-Catenin Circuit Is a Therapeutic Vulnerability for Primary and Drug Resistant Multiple Myeloma
Published in Blood (08-12-2017)“…Multiple Myeloma (MM) remains an incurable malignancy, despite the advent of several new therapeutic agents, including immunomodulatory drugs (IMiDs, e.g.,…”
Get full text
Journal Article -
9
Fostering Resilience: Teaching Social-Emotional Skills
Published in YC young children (01-07-2014)“…[...]Sylvia's parenting style became more consistent for Jake, lowering his stress levels and helping him respond to others. [...]more children wanted to play…”
Get full text
Journal Article -
10
Identification of Target Pathways Induced By the Multiple Myeloma Tumor Microenvironment Using Activity-Based Protein Profiling and Ex Vivo Protein Kinase Inhibitor Screening
Published in Blood (02-12-2016)“…Multiple myeloma (MM) is a heterogeneous plasma cell neoplasm that remains all but incurable despite recent advances in treatment. Indeed, nearly all patients…”
Get full text
Journal Article -
11
Abstract 503: Investigating the role of Tks5 and invadopodia in prostate tumor progression
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract Much of the morbidity and mortality in prostate cancer patients occurs strictly in response to metastatic disease. While ongoing efforts are examining…”
Get full text
Journal Article -
12
Identification and Characterization of CTX-M-Producing Shigella Isolates in the United States
Published in Antimicrobial agents and chemotherapy (01-05-2010)Get full text
Journal Article -
13
Src-Dependent Tks5 Phosphorylation Regulates Invadopodia-Associated Invasionin Prostate Cancer Cells
Published in The Prostate (30-10-2013)Get full text
Journal Article -
14
Evaluation of a 4-META adhesive cement
Published in Journal of esthetic dentistry (01-01-1991)“…This study investigated the shear bond strength of a new 4-META adhesive cement (C & B-Metabond) to dentin and Ni-Cr-Be alloy (Rexillium III). Fifteen human…”
Get more information
Journal Article -
15
A Comparative Analysis of Intelligence Coordination After the 9/11 Attack and the Second Gulf War : Selected Case Studies
Published 01-01-2008“…The dissertation aims to examine the intelligence coordination mechanisms in the US and UK with a view to comparing them and identifying similarities and…”
Get full text
Dissertation -
16
A description of the critical thinking skills observed in nursing students who use an interactive video program
Get full text
Dissertation -
17
Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody
Published in Journal of clinical oncology (01-04-1991)“…Sixteen patients with non-Hodgkin's lymphoma were infused with 6.2 to 58.2 mCi (0.2 to 3.9 mg) doses of radioactive iodine (131I)-labeled LL2 immunoglobulin G…”
Get more information
Journal Article -
18
Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14
Published in Cancer (15-03-1993)“…The authors previously reported that an anticarcinoembryonic antigen antibody against a carcinoembryonic antigen (CEA)-specific epitope is preferred for…”
Get more information
Journal Article -
19
A description of the critical thinking skills observed in nursing students who use an interactive video program
Published 01-01-1995“…The purpose of this study was to determine if nursing students use critical thinking skills when engaged with an interactive video program and if they could…”
Get full text
Dissertation -
20
Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas
Published in Cancer (01-02-1994)“…Colon-specific antigen-p is a tumor-associated antigen present in approximately 60% of colorectal cancers. Preclinical studies have shown that the murine…”
Get more information
Journal Article